Alamar Biosciences, a leader in precision proteomics, announced it will participate in the UBS Global Healthcare Conference on November 10 and Citi’s Global Healthcare Conference on December 2, 2026. The company will host a fireside chat and investor meetings, providing updates on its advanced protein detection technology. This participation highlights Alamar's efforts to engage investors and showcase its innovative platform for early disease detection. Interested parties can access live and archived webcasts on the company’s investor website.
Alamar Biosciences' upcoming participation in investor conferences is noted alongside the health sector's market activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 05, 2026 04:11 WIB: out of 150 priced US health-sector stocks, 108 rose and 42 fell. Notable movers include NVAX (Novavax Inc) at USD 10.64 with a 1-day change of +9.92% and Pluang order activity of 16% Sell / 84% Buy, NVST (Envista Holdings Corporation) at USD 27.17 with a +9.69% change, and THC (Tenet Healthcare Corporation) at USD 291.92 with a +9.46% change.
Fox Factory Holding Corp. has appointed Troy Henige as its new Chief Technology Officer (CTO) to lead the company's technology vision, strategy, and product roadmap. This new role aims to enhance innovation, connect engineering strengths across the c...
3M Company has reached a historic $7.35 billion settlement to resolve personal injury claims related to exposure to PFAS, toxic chemicals known as "forever chemicals." The settlement covers about 99% of existing claims, potentially benefiting 115,000...
The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North A...
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
